Besides, immune checkpoint inhibitors (ICIs) targeted programmed cell death protein 1 (PD-1)/programmed Cell Death-Ligand 1 (PD-L1) have been proved effective in the treatment of CRC [10, 11], revolutionizing oncotherapy to a great extent. Here, CD274 is linked to colorectal carcinoma.